Understanding Survival Analysis

LIVEWEBINARDHPAMA

Add to Calendar Understanding Survival Analysis 10/17/2022 4:30:00 PM 10/17/2022 5:45:00 PM Asia/Riyadh Online via Zoom false MM/DD/YYYY


Date & Location
Monday, October 17, 2022, 4:30 PM - 5:45 PM, Online via Zoom, Doha, Qatar

Overview
This webinar series is intended to enhance healthcare practitioners' understanding of biostatistical concepts used in research and thus enable them to correctly interpret the published literature and/or the results of data analyzes related to their projects . In this webinar, the speaker will present the concepts of time to event outcomes, censoring, the Kaplan Meier curve, hazard ratios and more. He will explain, with examples from the literature, how to interpret those statistics.

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians


Objectives
  1. Properly interpret descriptive and inferential statistics related to time to event data (survival analysis)

Registration

50 QAR - 14 USD

The registration closes ONE day before the activity. You will receive a UNIQUE join link on the day of the presentation.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to [email protected].

Changes or Cancellations

  • Name changes or substitutions are not permitted.
  • All cancellation and refund requests must be made in writing and submitted via email to [email protected]
  • For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
  • We will attempt to process the refund within 30 days of receiving any cancellation request.
  • Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

Accreditation



DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.25 hours.


ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Ziyad Mahfoud, PhD, Thurayya Arayssi, MD, Deema Al-Sheikhly, MRes, MEHP, Bruce MacRae, MSc, RRT, Maguy ElHajj, PharmD, Vahe Kehyayan, MSN, PhD, Daniel Rainkie, PharmD, Hatem Algraffee, BDS, have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Faculty: Ziyad Mahfoud, PhD, has no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Administrative Contact: Safia Rabia has no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.
 
The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.